Therapeutic Area | MeSH |
---|---|
musculoskeletal diseases | D009140 |
nutritional and metabolic diseases | D009750 |
Brand Name | Status | Last Update |
---|---|---|
bonsity | New Drug Application | 2025-06-01 |
forteo | New Drug Application | 2025-06-03 |
teriparatide | ANDA | 2025-07-14 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
postmenopausal osteoporosis | EFO_0003854 | D015663 | — |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Teriparatide, Forteo, Lilly | |||
7517334 | 2025-03-25 | DP |
Code | Description |
---|---|
J3110 | Injection, teriparatide, 10 mcg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoporosis | D010024 | EFO_0003882 | M81.0 | 10 | 29 | 18 | 26 | 28 | 108 |
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | 5 | 5 | 10 | 16 | 7 | 42 |
Metabolic bone diseases | D001851 | — | — | 1 | 7 | 2 | 4 | 3 | 17 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | 1 | 5 | 3 | 3 | 3 | 13 |
Spinal fractures | D016103 | EFO_0003902 | S12 | — | — | 1 | 1 | 3 | 5 |
Stress fractures | D015775 | — | M84.3 | — | — | 2 | 1 | 1 | 4 |
Spinal cord injuries | D013119 | EFO_1001919 | — | — | 3 | — | 1 | — | 4 |
Chronic kidney disease-mineral and bone disorder | D012080 | EFO_1001152 | N25.0 | — | — | 1 | 1 | 1 | 3 |
Osteogenesis imperfecta | D010013 | — | Q78.0 | — | 1 | — | 2 | — | 3 |
Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | 1 | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypoparathyroidism | D007011 | — | E20 | 1 | 9 | 6 | — | 3 | 17 |
Osteoporotic fractures | D058866 | — | — | — | 3 | 1 | — | 4 | 8 |
Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 2 | 1 | 3 | — | — | 6 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | 2 | 1 | — | 2 | 5 |
Hypocalcemia | D006996 | HP_0002901 | E83.51 | — | 3 | 1 | — | — | 4 |
Parathyroid diseases | D010279 | — | E21.5 | — | 1 | 3 | — | — | 4 |
Secondary hyperparathyroidism | D006962 | EFO_1001173 | — | — | — | 1 | — | 1 | 2 |
Anorexia | D000855 | — | R63.0 | — | 1 | 1 | — | — | 2 |
Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | — | 1 | 1 | — | — | 2 |
Femoral neck fractures | D005265 | EFO_1001792 | S72.00 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bone diseases | D001847 | — | M89.9 | 1 | 2 | — | — | 1 | 4 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 2 | — | — | 1 | 3 |
Musculoskeletal diseases | D009140 | — | — | 1 | 1 | — | — | — | 2 |
Colles' fracture | D003100 | — | S52.53 | — | 2 | — | — | — | 2 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | 1 | — | — | — | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | — | 1 | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | — | 1 | — | — | — | 1 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | 1 | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | — | 1 | — | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
Hyperparathyroidism | D006961 | EFO_0008506 | E21.3 | 2 | — | — | — | 1 | 3 |
Endocrine bone diseases | D001849 | — | — | 2 | — | — | — | — | 2 |
Hypercalcemia | D006934 | HP_0003072 | E83.52 | 1 | — | — | — | — | 1 |
Periodontitis | D010518 | EFO_0000649 | K05.3 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 1 | 1 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 1 | 1 |
Osteonecrosis | D010020 | EFO_0004259 | M87 | — | — | — | — | 1 | 1 |
Bisphosphonate-associated osteonecrosis of the jaw | D059266 | — | — | — | — | — | — | 1 | 1 |
Spontaneous fractures | D005598 | — | M84.4 | — | — | — | — | 1 | 1 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
Osteomalacia | D010018 | EFO_1002027 | M83 | — | — | — | — | 1 | 1 |
Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 1 | 1 |
Drug therapy | D004358 | — | — | — | — | — | — | 1 | 1 |
Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 1 | 1 |
Drug common name | Teriparatide |
INN | teriparatide |
Description | TERIPARATIDE |
Classification | Protein |
Drug class | peptides: parathyroid hormone related peptide |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C |
PDB | — |
CAS-ID | 52232-67-4 |
RxCUI | — |
ChEMBL ID | CHEMBL525610 |
ChEBI ID | — |
PubChem CID | 16132393 |
DrugBank | DB06285 |
UNII ID | 10T9CSU89I (ChemIDplus, GSRS) |